Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medexus Pharmaceuticals Inc
MEDXF
Primary Symbol:
T.MDP
Healthcare
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. The Company is focused on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy and dermatology. The Company has two divisions: Medexus Pharma Canada and Medexus Pharma USA...
. Medexus Pharma Canada division is a fully integrated commercial infrastructure focused on rheumatology, allergy, auto-immune disease, specialty oncology and pediatric diseases in Canada. The division’s prescription products include Metoject (Methotrexate Injection), Rupall (Rupatadine), Cuvposa (Glycopyrrolate Oral Solution), Pediapharm Naproxen Suspension (Naproxen) and others. Medexus Pharma USA division is a fully integrated commercial infrastructure focused on rheumatology and auto-immune diseases in the United States. The division’s products include Rasuvo, IXINITY and Gleolan.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(2)
•••
Paparico1
X
View Profile
View Bullboard History
Comment by
Paparico1
on Aug 15, 2023 2:55pm
RE:RE:Shorts
On 900 shares lol You probably the person who believes government should ban shorting. If I short, would only be on options and Mdp has no options. shorters balance the market, any smart
...more
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Aug 15, 2023 11:37am
RE:Shorts
You must be the chap fitting meaningless technical signals on such a lightly traded stock. Your posts always talks about pullbacks so, you are the shorter..
IAMGOLD Publishes 17th Annual Sustainability Report and Inaugural Tailings Management Report
posted May 17, 2024 9:00am by
IAMGOLD Corp
-
|
"IAMGOLD is dedicated to fostering sustainable practices that benefit communities, minimize environmental impacts, and uphold the highest standards of business integrity," said Renaud Adams, President and Chief Executive Officer of IAMGOLD. "The 2023 Sustainability Report marks the 17th year of annual reporting for IAMGOLD on the sustainability topics that are most material to our stakeholders and ...read more
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 15, 2023 11:34am
CEO Webinair
The link is below and very much worth listening to, as we have a very bright future that should sustain our 25% growth per year . Verging on $200 m cad in sales with a market cap of $55 million, it
...more
(2)
•••
Paparico1
X
View Profile
View Bullboard History
Post by
Paparico1
on Aug 14, 2023 8:25pm
Shorts
I personally don't like stocks with extremely low shorts. Last time shorts this low, MDP, July 30 2021 was 1.606 shares. Stock fell July 27 of 7.90 to Aug 3 2021 of 4.71. We are at 946 shares
...more
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 13, 2023 6:58pm
Getting the Share Price to $6.30
That is the conversion price of the Convertible Debenture due in early Oct of 2023. Removing this drag on our balance sheet would do wonders for the balance sheet and net margins. Tomorrow May be
...more
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 10, 2023 12:49pm
Price to book Valuation
Price top book includes debt and other balance sheet metrics which also makes it a valuable proxy tool. Price to book for this sector is trending around 7 times..see link below. This would place MDP
...more
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Aug 10, 2023 11:50am
RE:Very positive CC
The CD is convertible at a price of $6.30 per share some of which will be redeemed with the $20 m in cash expected to be in hand by September . This will considerably upside the balance sheet without
...more
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Aug 10, 2023 11:35am
RE:RE:Ebitda Sector Multiple
EV to Ebitda is 14.9.. https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/#:~:text=Worldwide%2C%20the%20average%20value%20of
...more
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 10, 2023 11:31am
Very positive CC
.Much info, and more will be provided when the company presents at the Share Series Event this coming Monday .. Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company
...more
(1961)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 10, 2023 7:40am
RE:RE:Ebitda Sector Multiple
With large o/s debt, EV/ebitda multiples are more relevant.
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Aug 10, 2023 7:25am
RE:Another Very Strong Quarter with 37% growth
What stands out in this first look at F2023/24 ( Q1 ) is the revenue growth rate of 37 %. This is statistically indifferent to the 39% growth observed in F22/23. Q1 is not the strongest quarter as
...more
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Aug 09, 2023 6:21pm
RE:Ebitda Sector Multiple
Ebitda of $6,6 million US in Q1 which is about $8.2 million in cad. Annualized, Thats about $33 million CAD Ebitda in this sector has a muktiple of 13 times ;( see my recent post ) which
...more
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 09, 2023 6:13pm
Another Very Strong Quarter with 37% growth
Fiscal Q1 2024 revenue reflects a 37% increase over fiscal Q1 2023, demonstrating strong revenue growth and continued overall performance Management to host conference call at 8:00 AM Eastern time
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 09, 2023 5:31pm
New Press Release - Medexus Announces Strong Fiscal Q1 2024 Results, Including Record Quarterly Revenue of US$31.6 Million
Fiscal Q1 2024 revenue reflects a 37% increase over fiscal Q1 2023, demonstrating strong revenue growth and continued overall performanceManagement to host conference call at 8:00 AM Eastern time on Thursday, August 10, 2023Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 9, 2023)...
read article.
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 05, 2023 4:57am
Exclusive Rights to Terbinafide HCL in Canada
Interestingly , it's the top treatment for toenail fungus .. https://www.verywellhealth.com/best-toenail-fungus-treatments-4174023
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment